» Articles » PMID: 39438795

Genomic Dynamics of High-risk Carbapenem-resistant Klebsiella Pneumoniae Clones Carrying Hypervirulence Determinants in Egyptian Clinical Settings

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Oct 22
PMID 39438795
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ongoing studies have revealed the global prevalence of severe infections caused by the hypervirulent strains of Klebsiella pneumoniae (K. pneumoniae). Meanwhile, the World Health Organization and the Centers for Disease Control declared carbapenem-resistant K. pneumoniae as an urgent public health threat, requiring swift and effective action to mitigate its spread. Low- and middle-income countries are severely impacted by such devastating infectious diseases owing to the ill implementation of antimicrobial practices and infection control policies. Having both hypervirulence and carbapenemase gene determinants, the emergence of convergent hypervirulent carbapenem-resistant K. pneumoniae is now being reported worldwide.

Methods: In this study, we sequenced 19 carbapenemase-producing K. pneumoniae strains recovered from various clinical specimens. Additionally, we evaluated the phenotypic antimicrobial susceptibility to multiple antimicrobial classes using the VITEK2 automated system. Utilizing the sequencing data, we characterized the sequence types, serotypes, pangenome, resistance profiles, virulence profiles, and mobile genetic elements of the examined isolates. We highlighted the emergence of high-risk clones carrying hypervirulence genetic determinants among the screened isolates.

Results: Our findings revealed that all carbapenem-resistant isolates exhibited either extensive- or pan-drug resistance and harbored multiple variants of resistance genes spanning nearly all the antimicrobial classes. The most prevalent carbapenemase genes detected within the isolates were bla and bla. We identified high-risk clones, such as ST383-K30, ST147-K64, ST11-K15, and ST14-K2, which may have evolved into putative convergent strains by acquiring the full set of hypervirulence-associated genetic determinants (iucABCD, rmpA and/ or rmpA2, putative transporter peg-344). Additionally, this study identified ST709-K9 as a high-risk clone for the first time and uncovered that capsule types K15 and K9 carried hypervirulence genetic determinants. The most frequent Inc types found in these isolates were Col440I, IncHI1B, and Inc FII(K).

Conclusion: This study highlights the emergence of high-risk, extensively carbapenem-resistant K. pneumoniae strains co-carrying hypervirulence determinants in Egyptian clinical settings. This poses an imminent threat not only to Egypt but also to the global community, underscoring the urgent need for enhanced surveillance and control strategies to combat this pathogen.

References
1.
Podschun R, Ullmann U . Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998; 11(4):589-603. PMC: 88898. DOI: 10.1128/CMR.11.4.589. View

2.
Chen C, Tang H, Chiou C, Tung K, Lu M, Lai Y . Colonization dynamics of Klebsiella pneumoniae in the pet animals and human owners in a single household. Vet Microbiol. 2021; 256:109050. DOI: 10.1016/j.vetmic.2021.109050. View

3.
Rocha J, Henriques I, Gomila M, Manaia C . Common and distinctive genomic features of Klebsiella pneumoniae thriving in the natural environment or in clinical settings. Sci Rep. 2022; 12(1):10441. PMC: 9213442. DOI: 10.1038/s41598-022-14547-6. View

4.
Paczosa M, Mecsas J . Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016; 80(3):629-61. PMC: 4981674. DOI: 10.1128/MMBR.00078-15. View

5.
Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L . A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2017; 18(1):37-46. DOI: 10.1016/S1473-3099(17)30489-9. View